EcoDrugPlus

A-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSDARG00000054533
Gene Symbol: ARAF
10 Enzyme and pathways 5 Cross references
191 Possible Orthologues:

Adam Metallopeptidase Domain 17a

Ensembl ID : ENSDARG00000043213
Gene Symbol: ADAM17A
5 Enzyme and pathways 5 Cross references
209 Possible Orthologues:

Adam Metallopeptidase Domain 17b

Ensembl ID : ENSDARG00000093093
Gene Symbol: ADAM17B
5 Cross references
210 Possible Orthologues:

Adam Metallopeptidase With Thrombospondin Type 1 Motif 5

Ensembl ID : ENSDARG00000100307
Gene Symbol: ADAMTS5
6 Enzyme and pathways 4 Cross references
199 Possible Orthologues:

Alk Receptor Tyrosine Kinase

Ensembl ID : ENSDARG00000095833
Gene Symbol: ALK
5 Cross references
195 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSDARG00000045843
Gene Symbol: APEX1
9 Enzyme and pathways 5 Cross references
214 Possible Orthologues:

Aph1b Gamma Secretase Subunit

Ensembl ID : ENSDARG00000005612
Gene Symbol: APH1B
5 Cross references
186 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 1

Ensembl ID : ENSDARG00000104719
Gene Symbol: ABCC1
10 Enzyme and pathways 5 Cross references
203 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8

Ensembl ID : ENSDARG00000051879
Gene Symbol: ABCC8
7 Enzyme and pathways 5 Cross references
230 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 8b

Ensembl ID : ENSDARG00000077007
Gene Symbol: ABCC8B
5 Cross references
169 Possible Orthologues:

Atp-Binding Cassette, Sub-Family C (Cftr/mrp), Member 9

Ensembl ID : ENSDARG00000015985
Gene Symbol: ABCC9
9 Enzyme and pathways 5 Cross references
233 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Alpha 1a, Tandem Duplicate 1

Ensembl ID : ENSDARG00000002791
Gene Symbol: ATP1A1A.1
6 Enzyme and pathways 5 Cross references
290 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).